Appetite changes often occur first, followed by gradual weight loss as calorie intake decreases and the body begins utilizing stored fat for energy
Medication access through Willow reflects several conditions that are disclosed only at a high level: A completed online intake is required before any medication discussion occurs
effective/dated: August 25, 2025
Best for: Muscle injuries, multiple concurrent injuries, systemic inflammation Distribution: Whole-body via bloodstream Dosing frequency: Twice weekly during loading, once weekly maintenance Half-life: 24 to 48 hours Unique benefit: Reaches all injury sites from single injection Human Clinical Evidence Human clinical trials for Tb-500 remain remarkably sparse given its widespread underground use, but more data exists than for Bpc-157
By improving appetite control, insulin sensitivity, and metabolic function, these injections set the stage for lasting results